Genmab — December 2019
-
-
Generelt er det en god ide at lytte til Genmabchatten, hvis du vil vide noget om Genmab som f.eks at den er underpriset gennem et par år, grundet dårlige analytikere og PE-folket der ikke fatter hvad type virksomhed der er tale om. At stigningen skyldes nævnte + ASH, shortere ud, milestone som lige er tikket ind, positionering til guiding og mulig nyt fra pipeline, samarbejdspartnere og andet spændende.
-
Nyt partnerskab. Det det er jeg meget stolt af. https://blog.nordnet.dk/nordnet-blandt-de-mest-anbefalede-brands/
-
Novartis R&D presentation if you are interested via https://www.novartis.com/news/novartis-rd-day
. "Planning to complete regulatory filings in December (US)
2019 and January (EU) 2020" Switzerland H12020, Japan H2 2020
Og da det var 8. jan i år vi fik medd. omHello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind